Verizon Officer Kyle Malady Files Form 144 to Sell 1,100 Shares Under Rule 10b5-1 Plan
VERIZON COMMUNICATIONS INC
Subscribe to track VZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: Verizon Communications Inc. ($VZ) Insider: Kyle Malady (Officer) Shares to Sell: 1,100 Common Shares Market Value: $47,223.00 (~$42.93/share) Trading Significance: Low (Routine 10b5-1 Plan Execution)
Comprehensive Analysis
Overview
On October 13, 2026, Kyle Malady, an Officer of Verizon Communications Inc. (NYSE: VZ), filed Form 144 noticing a proposed sale of 1,100 shares of common stock with an aggregate market value of approximately $47,223.00 through Fidelity Brokerage Services LLC.
Transaction Details
- Security: Common Stock
- Shares Proposed for Sale: 1,100
- Estimated Price per Share: ~$42.93
- Aggregate Market Value: $47,223.00
- Approximate Sale Date: October 13, 2026
- Origin of Securities: Restricted stock vesting on March 1, 2026, as executive compensation.
Plan and Prior Activity
- Rule 10b5-1 Adoption: The sale is being executed under a Rule 10b5-1 trading plan adopted on May 18, 2026.
- Past 3 Months Activity: The insider has consistently sold 1,100 shares on a weekly schedule dating back to mid-August 2026, generating gross proceeds ranging between $50,325 and $56,309 per tranche.
Market Significance
This filing reflects routine execution under a pre-established Rule 10b5-1 trading plan. Given the small transaction size relative to Verizon's over 4.15 billion shares outstanding, this filing carries minimal market impact and is classified as Low significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
